Gary J. Appio is Executive Director, Regulatory Affairs (Risk Management) at Jazz Pharmaceuticals Inc. He is responsible for strategic and tactical support of Jazz’s risk management activities related to FDA required Risk Evaluation and Mitigation Strategies (REMS) and Global Risk Management Plans. He provides expert opinion on risk management support for products in early development to assist in shaping risk management and risk communication strategies for patients and healthcare professionals. Before this role, Dr. Appio was Head of US Safety Risk Management at Novartis Pharmaceuticals Corporation where he created the REMS department and 13 REMS programs.
Prior to Novartis, he worked 11 years at St. Francis Medical Center in Trenton, NJ in several clinical staff and leadership positions including Hospital Pharmacy Director.
Dr. Appio earned his BS in Pharmacy from Rutgers University, PharmD from the University of Florida, and holds an MBA from the University of Massachusetts, Amhearst.